Medicago Planning Vaccine Production Facility in Durham, North Carolina
08/10/2010
"North Carolina's quality of work force, its training programs, and overall understanding of biotech development models were critical factors in our decision to locate in RTP," said Andy Sheldon, president and CEO of Medicago. "We are thrilled with our decision to build our vaccine facility in one of the largest and successful technology parks."
Medicago has received a $21 million research grant from the Defense Advanced Research Projects Agency (DARPA) to improve the production process of H1N1 vaccines. The company's project represents a total investment of more than $32 million in Research Triangle Park.
Project Announcements
Oldcastle APG Plans Lancaster, South Carolina, Operations
05/10/2025
Vantive Plans Deerfield, Illinois, Headquarters Operations
05/10/2025
SkyWest Airlines Plans Shreveport, Louisiana, Maintenance Operations
05/10/2025
Hissho Sushi Plans Rock Hill, South Carolina, Headquarters-Distribution Operations
05/09/2025
Nelson Brothers Expands Walker County, Alabama, Operations
05/04/2025
Kimberly-Clark Expands Aiken County, South Carolina, Distribution Operations
05/04/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024